These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38520220)

  • 1. Prognostic and immunotherapeutic potential of regulatory T cell-associated signature in ovarian cancer.
    Liu Y; Shan F; Sun Y; Kai H; Cao Y; Huang M; Liu J; Zhang P; Zheng Y
    J Cell Mol Med; 2024 Apr; 28(8):e18248. PubMed ID: 38520220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
    Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
    Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis from multi-center studies identifies a weighted gene co-expression network analysis-based Tregs signature in ovarian cancer.
    Cao Y; Liu YL; Lu XY; Kai HL; Han Y; Zheng YL
    Environ Toxicol; 2024 Feb; 39(2):736-750. PubMed ID: 37713585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
    Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single‑cell RNA sequencing reveals heterogeneity in ovarian cancer and constructs a prognostic signature for prognostic prediction and immunotherapy.
    Zhou S; Li H; Zhao C; Zhao W; Pan X; Jian W; Wang J
    Int Immunopharmacol; 2024 Oct; 140():112855. PubMed ID: 39133955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
    Duan Y; Xu X
    Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer.
    Chen SF; Wang LY; Lin YS; Chen CY
    J Ovarian Res; 2024 Sep; 17(1):190. PubMed ID: 39342345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes.
    Gao W; Yuan H; Yin S; Deng R; Ji Z
    J Ovarian Res; 2024 Oct; 17(1):208. PubMed ID: 39434163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism-related gene vaccines and immune infiltration in ovarian cancer: A novel risk score model of machine learning.
    Fu Y; Huang Z; Huang J; Xiong J; Liu H; Wan X
    J Gene Med; 2024 Jan; 26(1):e3568. PubMed ID: 37455244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
    Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
    Front Immunol; 2021; 12():788431. PubMed ID: 34970268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of NK Marker Genes in Ovarian Cancer by scRNA-seq Combined with WGCNA Algorithm.
    He X; Feng W
    Mediators Inflamm; 2023; 2023():6845701. PubMed ID: 37144238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.
    Huang P; Zhou X; Zheng M; Yu Y; Jin G; Zhang S
    Front Immunol; 2023; 14():1263537. PubMed ID: 37767092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and
    Xu W; Zhang W; Zhao D; Wang Q; Zhang M; Li Q; Zhu W; Xu C
    Front Immunol; 2023; 14():1242909. PubMed ID: 37753069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.
    Zhang P; Dong S; Sun W; Zhong W; Xiong J; Gong X; Li J; Lin H; Zhuang Y
    Front Mol Biosci; 2023; 10():1277530. PubMed ID: 37842637
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer.
    Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y
    Front Immunol; 2024; 15():1228235. PubMed ID: 38404588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Immune Infiltration-related Molecular Features in Ovarian Cancer Patients and Experimental Validation of Immune Response Molecular Mechanisms through Integrated WGCNA, Machine Learning, and Single-cell Sequencing Analysis.
    Yang J; Wen C; Li P; Yao M; Wang J
    Recent Pat Anticancer Drug Discov; 2024 Jul; ():. PubMed ID: 39034722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.